In vivo therapy of myocardial infarction with mesenchymal stem cells modified with prostaglandin I synthase gene improves cardiac performance in mice
- 1 February 2011
- journal article
- Published by Elsevier in Life Sciences
- Vol. 88 (9-10) , 455-464
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Genetic Modification of Mesenchymal Stem Cells Overexpressing CCR1 Increases Cell Viability, Migration, Engraftment, and Capillary Density in the Injured MyocardiumCirculation Research, 2010
- Combination of chemokine and angiogenic factor genes and mesenchymal stem cells could enhance angiogenesis and improve cardiac function after acute myocardial infarction in ratsMolecular and Cellular Biochemistry, 2010
- Combining neuropeptide Y and mesenchymal stem cells reverses remodeling after myocardial infarctionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- The anti-apoptotic protein HAX-1 is a regulator of cardiac functionProceedings of the National Academy of Sciences of the United States of America, 2009
- Enhancement of Myocardial Regeneration Through Genetic Engineering of Cardiac Progenitor Cells Expressing Pim-1 KinaseCirculation, 2009
- Cardiac Progenitor Cells and Biotinylated Insulin-Like Growth Factor-1 Nanofibers Improve Endogenous and Exogenous Myocardial Regeneration After InfarctionCirculation, 2009
- Early Beneficial Effects of Bone Marrow-Derived Mesenchymal Stem Cells Overexpressing Akt on Cardiac Metabolism After Myocardial InfarctionStem Cells, 2009
- Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for HomingStem Cells, 2007
- Prostacyclin production is not controlled by prostacyclin synthase but by cyclooxygenase-2 in a human follicular dendritic cell line, HKMolecular Immunology, 2007
- Emerging evidence for the role of cardiotrophin-1 in cardiac repair in the infarcted heartCardiovascular Research, 2005